Press release
Rise In Prevalence Of Kidney Cancer Drives Growth In The Diagnostics And Therapeutics Market Driver: Leading Transformation in the Kidney Cancer Diagnostics And Therapeutics Market in 2025
Kidney Cancer Diagnostics And Therapeutics Market Size
The growth of the kidney cancer diagnostics and therapeutics market is predicted to surge owing to the rising occurrence of kidney cancer. The disease, kidney cancer is characterized by an abnormal transformation and uncontrollable growth of healthy cells in one or both the kidneys, leading to the development of a mass known as renal cortical tumor. Diagnostics and therapeutics are vital to the control and treatment of this disease, providing myriad benefits to patients including early detection, precise diagnosis, targeted treatment strategies, and continuous treatment monitoring. For example, the American Society of Clinical Oncology (ASCO), a non-profit organization dedicated to cancer care based in the United States, predicts that in March 2023, kidney cancer would be diagnosed in 81,800 individuals across the US (52,360 males and 29,440 females). Data from 2020 shows that globally, kidney cancer impacted 431,288 individuals. Hence, this rising occurrence of kidney cancer is likely to boost the growth of the kidney cancer diagnostics and therapeutics market.
Get Your Kidney Cancer Diagnostics And Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report
What is the projected compound annual growth rate (CAGR) of the kidney cancer diagnostics and therapeutics market from 2025 to 2034, and what factors influence it?
In recent times, the market cap for kidney cancer diagnostic and treatment methods has experienced pronounced growth. The market, which stood at $4.1 billion in 2024, is predicted to expand to $4.32 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. The remarkable growth noted in the historic timescale can be attributed to advanced research in molecular biology and genetic breakthroughs, improvements in healthcare accessibility, surgical technological advancements, clinical trials, and development of new drugs.
In the coming years, it is projected that the kidney cancer diagnostics and therapeutics market will experience robust growth, increasing in value to $5.68 billion by 2029 at a compound annual growth rate (CAGR) of 7.0%. This growth over the predicted period owes to factors such as developments in biomarker research, genomic sequencing techniques, the use of telemedicine and remote consultations, advancements in precision medicine, and the emergence of rapid diagnostic technologies. The integration of palliative care, the provision of care for long-term survivors, interventions in nutrition and lifestyle, the growing influence of radiomics, and the adoption of liquid biopsies are all trends that could characterize this market in the forecast period.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp
How are the latest trends influencing the growth of the kidney cancer diagnostics and therapeutics market?
Several leading companies in the kidney cancer diagnostics and therapeutics market are putting in efforts to devise new and advanced treatments for renal cell carcinoma (RCC) with the goal to enhance patient results and offer innovative therapeutic options that are tailor-made for specific requirements of those diagnosed with this complex disease. The necessity for RCC research is imperative for kidney cancer diagnostics and therapeutics as it leads to the innovation of state-of-the-art diagnostic procedures and targeted treatments that promote early detection and personalized patient care. For instance, Merck, a pharmaceutical company from the United States, introduced welireg (belzutifan), the first-ever HIF-2a inhibitor approved in December 2023 for the treatment of adults with advanced RCC who have already undergone PD-1 or PD-L1 inhibitors, and VEGF-TKIs treatments. This revolutionary treatment category provides significant advantages like extended progression-free survival and increased response rates in contrast to everolimus. The approval of WELIREG is a significant leap forward in the kidney cancer diagnostics and therapeutics market, creating renewed hope for patients with advanced disease.
What are the major segments of the kidney cancer diagnostics and therapeutics market and their role in driving growth?
The kidney cancer diagnostics and therapeutics market covered in this report is segmented -
1) By Cancer Type: Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types
2) By Component: Drugs, Diagnostics
3) By Diagnostics: Biopsy, CT Scan, Nephro-Ureteroscopy, Intravenous Pyelogram, Ultrasound
4) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy
5) By End-Users: Hospitals, Pharmaceutical Labs, Genomics Laboratories
Subsegments:
1) By Clear Cell RCC: Stage I, Stage II, Stage III, Stage IV
2) By Papillary RCC: Type 1, Type 2
3) By Chromophobe RCC: Localized, Advanced
4) By Urothelial Carcinoma And Transitional Cell Carcinoma: Non-muscle invasive, Muscle invasive, Metastatic
5) By Other Cancer Types: Collecting Duct Carcinoma, Renal Medullary Carcinoma, Other rare types
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11937
Which regions are key players in the growth of the kidney cancer diagnostics and therapeutics market?
North America was the largest region in the kidney cancer diagnostics and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney cancer diagnostics and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the kidney cancer diagnostics and therapeutics market?
Major companies operating in the kidney cancer diagnostics and therapeutics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Pharmaceuticals Limited, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Eisai Co. Ltd., Illumina Inc., PerkinElmer Inc., Ipsen S.A, Bio-Rad Laboratories Inc., QIAGEN NV, Exelixis Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., GeneDx LLC, CD Genomics, Genpath Life Sciences Private Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp
What Is Covered In The Kidney Cancer Diagnostics And Therapeutics Global Market Report?
• Market Size Forecast: Examine the kidney cancer diagnostics and therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the kidney cancer diagnostics and therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the kidney cancer diagnostics and therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the kidney cancer diagnostics and therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the kidney cancer diagnostics and therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the kidney cancer diagnostics and therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the kidney cancer diagnostics and therapeutics market.
• Competitive Landscape: Review strategic developments in the kidney cancer diagnostics and therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise In Prevalence Of Kidney Cancer Drives Growth In The Diagnostics And Therapeutics Market Driver: Leading Transformation in the Kidney Cancer Diagnostics And Therapeutics Market in 2025 here
News-ID: 3897807 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
